You have no items in your shopping cart.
Necrosis & Necroptosis Inhibitors
Necrosis & Necroptosis play a prominent role in a wide range of human pathological conditions. AG Scientific provides Necrosis & Necroptosis inhibitor for In vitro studies such as neurotoxic, cold stress, hypoxic injury and oxidative stress (ROS/RNS) and In vivo studies such as stroke, myocardial infarct, ischemic injury and neurodegeneration.
AG Scientific can ship FedEx directly to your lab, from small-scale to bulk orders. Our leadership in bulk supply allows us to provide custom product packaging and create multiple product forms. We offer “just in time” delivery, private labeling, and custom formulations for specific research needs.
Below find the most popular Necrosis Inhibitors and links to FREE REVIEW ARTICLES on this field of interest.
- Anti-Tumor Necrosis Factor Inhibitor Therapy-induced Dermatomyositis and Fasciiti, GIOVANNA RIOLO and TANVEER E. TOWHEED. Anti-Tumor Necrosis Factor Inhibitor Therapy-induced Dermatomyositis and Fasciitis. J Rheumatol, 2012; 39: 192 - 194.
- New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?, David L Scott and Andrew Cope. New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice? Ann Rheum Dis, 2009; 68: 767 - 769.
- Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans?, GIDEON KOREN and MIHO INOUE. Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans? J Rheumatol, 2009; 36: 465 - 466.